Table 4.
Differences in levels of validation response indexes after intervention between two groups ( ± SD).
| Inflammatory indexes | Intervention group (n = 48) | Control group (n = 48) | t | P |
|---|---|---|---|---|
| IL-6 (ng/L) | 247.67 ± 25.93 | 279.36 ± 25.48 | 6.039 | ＜0.001 |
| IL-8 (pg/ml) | 325.83 ± 32.19 | 350.74 ± 35.72 | 3.589 | 0.001 |
| PSP (ng/ml) | 40.90 ± 8.16 | 49.98 ± 9.63 | 4.984 | ＜0.001 |
| NE (μg/L) | 153.77 ± 34.57 | 207.24 ± 38.37 | 7.713 | ＜0.001 |
| su-PAR (ng/ml) | 8.21 ± 2.15 | 12.06 ± 2.42 | 8.240 | ＜0.001 |
| IL-35 (pg/ml) | 30.96 ± 4.77 | 37.78 ± 4.85 | 6.946 | ＜0.001 |
| sTREM-1 (pg/ml) | 174.13 ± 26.32 | 188.53 ± 29.59 | 2.519 | 0.013 |
| PTX-3 (ng/ml) | 14.25 ± 6.42 | 21.39 ± 8.74 | 4.562 | ＜0.001 |
| PCT (μg/L) | 0.57 ± 0.20 | 0.79 ± 0.26 | 9.833 | ＜0.001 |